Insulin, insulin-like growth factor-1, and insulin resistance in women with pregnancy-induced hypertension

American Journal of Obstetrics and Gynecology

Volumn 187, Issue 3, 2002, Pages 735-740

  Bartha, Jose L ^a   Romero Carmona, Raquel ^a   Torrejon Cardoso, Rafael ^a   Comino Delgado, Rafael ^a  

^a HOSPITAL UNIVERSITARIO DE PUERTO REAL   (Spain)

Author keywords

Insulin resistance; Insulin like growth factor I; Preeclampsia; Pregnancy induced hypertension

Indexed keywords

C PEPTIDE; FRUCTOSAMINE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HUMAN INSULIN; INSULIN; LIPID; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN C;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; INSULIN BLOOD LEVEL; INSULIN METABOLISM; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; LIPID ANALYSIS; MATERNAL HYPERTENSION; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE;

EID: 0036740333     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2002.126283     Document Type: Article

References (17)

1. Joffe GM, Esterlitz JR, Levine RJ, Clemens JD, Ewell MG, Sibai BM, et al. The relationship between abnormal glucose tolerance and hypertensive disorders of pregnancy in healthy nulliparous women: Calcium for Preeclampsia Prevention (CPEP) study group. Am J Obstet Gynecol 1998;179:1032-7.
2. Roberts RN, Henriksen JE, Hadden DR. Insulin sensitivity in pre-eclampsia. Br J Obstet Gynaecol 1998;105:1095-100.
3. Caruso A, Ferrazzani S, De Carolis S, Lucchese A, Lanzone A, De Santis L, et al. Gestational hypertension but not pre-eclampsia is associated with insulin resistance syndrome characteristics. Hum Reprod 1999; 14:219-23.
4. Kaaja R, Laivuori H, Laakso M, Tikkanen MJ, Ylikorkala O. Evidence of a state of increased insulin resistance in preeclampsia. Metabolism 1999;48:892-6.
5. Laviades C, Gil MJ, Monreal I, González A, Diez J. Tissue availability of insulin-like growth factor I is inversely related to insulin resistance in essential hypertension: effects of angiotensin converting enzyme inhibition. J Hypertens 1998;16:863-70.
6. Giudice LC, Martina NA, Crystal RA, Tazuke S, Druzin M. Insulin-like growth factor binding protein-1 at the maternal-fetal interface and insulin-like growth factor-I, insulin-like growth factor-II, and insulin-like growth factor binding protein-1 in the circulation of women with severe preeclampsia. Am J Obstet Gynecol 1997;176:751-7.
7. Bartha JL, Comino-Delgado R. Carbohydrate metabolism: evaluation in women with de novo hypertension in late pregnancy. J Reprod Med 1997;42:489-96.
8. Bonora E, Moghetti B, Zancanaro C, Cigolini M, Querena M, Cacciatori V, et al. Estimates of in vivo insulin in man: comparison of insulin tolerance test with euglycemic and hyperglycemic glucose clamp studies. J Clin Endocrinol Metab 1989;68:374-8.
9. Grulet H, Durlach V, Hecart AC, Griss A, Leutenegger M. Study of the rate of early glucose disappearance following insulin injection: insulin sensitivity index. Diabetes Res Clin Pract 1993;20:201-7.
10. Bartha JL, Comino-Delgado R, Martínez del Fresno P, Fernández-Barrios M, Bethencourt I, Moreno-Corral L. Insulin-sensitivity index and carbohydrate and lipid metabolism in gestational diabetes. J Reprod Med 2000;45:185-9.
11. Haffner SM. Sex hormone-binding protein, hyperinsulinemia, insulin resistance and noninsulin-dependent diabetes. Horm Res 1996;45:233-7.
12. Bartha JL, Comino-Delgado R, Romero-Carmona R, Gómez-Jaen MC. Sex hormone-binding globulin in gestational diabetes. Acta Obstet Gynecol Scand 2000;79:839-45.
13. Kaaja R, Tikkanen MJ, Viinikka L, Ylikorkala O. Serum lipoproteins, insulin, and urinary prostanoid metabolites in normal and hypertensive pregnant women. Obstet Gynecol 1995;85:353-6.
14. Randle PJ. Regulatory interactions between lipids and carbohydrates: the glucosa fatty acid cycle alter 35 years. Diabetes Metab Rev 1998;14:263-83.
15. Grobman WA, Kazer RR. Serum insulin, insulin-like growth factor-I, and insulin-like growth factor binding protein-1 in women who develop preeclampsia. Obstet Gynecol 2001;97:521-6.
16. Cusi K, DeFronzo R. Recombinant human insulin-like growth factor I treatment for 1 week improves metabolic control in type 2 diabetes by ameliorating hepatic and muscle insulin resistance. J Clin Endocrinol Metab 2000;85:3077-84.
17. Holmes RP, Holly JM, Soothill PW. A prospective study of maternal serum insulin-like growth factor-I in pregnancies with appropriately grown or growth restricted fetuses. Br J Obstet Gynaecol 1999;106:1232-3.